PATENT CLAIM ANALYSIS

Application Number: 16059715
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["546", "304000"]

Abstract:
The present invention is directed to compounds of formula (I) which are inhibitors of the BACE1 enzyme. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders for which the reduction of Aβ deposits is beneficial such as Alzheimer's disease.

Claim (Index 11):
A pharmaceutical composition comprising a compound according to anyone of  claims 1 - 10  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 96.0
- Lexical Diversity: 1.4359
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14933301', '15524565', '15524479', '15524546', '15233463']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8271854847018818
- 35 USC 102 Novelty (BERT): 0.6012045834416303
- Combined Prediction Score: 0.8045873945758567
- Mean Citation Score: 463.81169400000016
- Max Citation Score: 552.2594
- Similarity Product: 487.203639161396

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test